arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

HYPERION DEFI, INC.

HYPD
$2.71 ▲ +0.04 (+1.50%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
39 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
14
Health
Poor
Bearish
auto_awesome

Analytical Summary

HYPERION DEFI, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $28.8M
Dividend Yield
Revenue Growth 1559.4%
Op. Margin None
ROIC 11.8%
FCF / Share $-0.40
Trailing P/E 9.0x
Price / Book 0.5x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

39-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$244.27K
↑ +1559.4%
Net Income Profit after all expenses
$8.84M
↑ +122.2%
Operating Margin Operating profit as % of sales
30.5%
↑ +112.8%
FCF / Share Free cash flow per share
$-0.40
↑ +80.5%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
8
Financial Health
12
Cash Quality
33

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 11 years · 39 quarters